The American Intellectual Property Law Association (AIPLA) will be offering a webinar on "Teva: The Real Impact on Claim Construction Tactics in the PTAB, Federal Courts, and ITC" on July 29, 2015 from 12:30 - 2:00 pm (Eastern). Cory Bell of Finnegan, Robert Counihan of White and Case, and Jonathan Stroud of Unified Patents will explore the implications of the Teva Supreme Court decision on claim construction in both district courts and at the PTAB, whether the adoption of clear error review will have a significant impact on claim construction practices, and other best practices and strategies for developing a winning claim construction.
The registration fee for the program is $145 (AIPLA member rate) or $195 (non-member rate). Those interested in registering for the program, can do so here.
Comments